Piotr Maslak

Piotr Maślak is Senior Director and Head of Emerging Technologies at AstraZeneca. He leads global efforts to transform clinical trials with digital platforms and AI – accelerating development and making research more patient-centric. Piotr has a track record of scaling enterprise AI strategies and driving award-winning innovation. Recognized for driving digital transformation in pharmaceutical industry, he is passionate about challenging conventions and shaping the future of clinical research.

Frank Maier

Frank Maier provides operational leadership and functional oversight of Project Management, specializing in medical device and IVD studies. He has more than 15 years of CRO experience managing international clinical investigations, spanning a wide range of therapeutic areas and study designs. He is an expert in applying regulatory requirements such as ISO 14155, ISO 20916, (EU) MDR 2017/745, (EU) IVDR 2017/746, relevant MDCG guidelines and GDPR. Frank has experience in pre- and post-market clinical investigations including EU-wide submissions and provides effective leadership to teams and excels in strategic planning and creative problem-solving. He participates in inspections and audits, including conducting ISO 14155 audits of customers. Frank holds a Specialized Registered Nursing degree in intensive care.